about
Cyclopeptides containing the DEKS motif as conformationally restricted collagen telopeptide analogues: synthesis and conformational analysis.Imaging of α7 nicotinic acetylcholine receptors in brain and cerebral vasculature of juvenile pigs with [(18)F]NS14490.EGF receptor-targeting peptide conjugate incorporating a near-IR fluorescent dye and a novel 1,4,7-triazacyclononane-based (64)Cu(II) chelator assembled via click chemistry.New systematically modified vesamicol analogs and their affinity and selectivity for the vesicular acetylcholine transporter - A critical examination of the lead structure.Direct and Auger Electron-Induced, Single- and Double-Strand Breaks on Plasmid DNA Caused by 99mTc-Labeled Pyrene Derivatives and the Effect of Bonding DistanceGelatin-based Hydrogel Degradation and Tissue Interaction in vivo: Insights from Multimodal Preclinical Imaging in Immunocompetent Nude Mice.Development of (18)F-labeled radiotracers for neuroreceptor imaging with positron emission tomographySpatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure.(99m)Tc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging.ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.Development of indazolylpyrimidine derivatives as high-affine EphB4 receptor ligands and potential PET radiotracers.(18)F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ1 Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging Agent.(177)Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment.Radiofluorination and first radiopharmacological characterization of a SWLAY peptide-based ligand targeting EphA2.Novel cyclopentadienyl tricarbonyl (99m)tc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors.Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice.Cytotoxic properties of radionuclide-conjugated Cetuximab without and in combination with external irradiation in head and neck cancer cells in vitro.Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential.Radiosynthesis and biological evaluation of the new PDE10A radioligand [18 F]AQ28A.Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of σ₁ Receptors.Evaluation of in vivo quantification accuracy of the Ingenuity-TF PET/MR.Synthesis and biodistribution studies of (3)H- and (64)Cu-labeled dendritic polyglycerol and dendritic polyglycerol sulfate.An efficient bioorthogonal strategy using CuAAC click chemistry for radiofluorinations of SNEW peptides and the role of copper depletion.A fluoro versus a nitro derivative-a high-performance liquid chromatography study of two basic analytes with different reversed phases and silica phases as basis for the separation of a positron emission tomography radiotracer.Synthesis and biological evaluation of both enantiomers of [(18)F]flubatine, promising radiotracers with fast kinetics for the imaging of α4β2-nicotinic acetylcholine receptors.LC-MS Supported Studies on the in Vitro Metabolism of both Enantiomers of Flubatine and the in Vivo Metabolism of (+)-[(18)F]Flubatine-A Positron Emission Tomography Radioligand for Imaging α4β2 Nicotinic Acetylcholine Receptors.Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.Recent progress using the Staudinger ligation for radiolabeling applications.Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography.Distinctive in vivo kinetics of the new σ1 receptor ligands (R)-(+)- and (S)-(-)-18F-fluspidine in porcine brain.Preparation of a novel radiotracer targeting the EphB4 receptor via radiofluorination using spiro azetidinium salts as precursor.Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.Synthesis and evaluation of a (18) F-labeled 4-phenylpiperidine-4-carbonitrile radioligand for σ1 receptor imaging.Automation of the radiosynthesis and purification procedures for [18F]Fluspidine preparation, a new radiotracer for clinical investigations in PET imaging of σ(1) receptors in brain.Development of a Novel Nonpeptidic (18)F-Labeled Radiotracer for in Vivo Imaging of Oxytocin Receptors with Positron Emission Tomography.Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells.Impact of pre- and early per-treatment FDG-PET based dose-escalation on local tumour control in fractionated irradiated FaDu xenograft tumours.Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.Novel (pyrazolyl)benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors.An automatic method for accurate volume delineation of heterogeneous tumors in PET.
P50
Q30878012-6191550C-8BD1-471E-97C2-D47DA57F6197Q34031006-ABFA3B22-138D-4CE3-970F-8964F81C7EB2Q35155716-2692254A-6BB1-4AD9-873D-3EF560DB1990Q35662872-D43E6E32-C3DC-4D56-8294-3F0658C4842DQ36119779-2A5DDFBF-0DB0-4CFF-963E-4C291AAD6B60Q37291281-9CBD9F56-BBE0-42B3-9CF8-E657456B9F40Q38244707-EC95FD48-1D7E-4A6B-AB05-B923587C452FQ38412352-530ECAB5-E8C3-4EB3-BA93-85550466FADEQ38805895-5B91CEA8-7A8A-4205-ADD2-00A2E64C824DQ38814097-99E16FEE-E2B9-4E5C-A8BE-CACDC2C6050FQ38851554-61ADA716-4085-4463-A4FB-AF3E1053B970Q38862247-A24599B9-448B-4913-A383-AE3174DE62B0Q38919414-9E90AAB9-E620-4539-B634-2A1062C90ACDQ38952546-E187052A-41BF-41BF-846B-33AF46CB09A5Q38970610-37E43CC8-C281-4A8A-9238-74A6D64EE810Q39014702-62CE68C1-9F9A-448C-8C08-59E13721AB87Q39018435-36518D40-DAB3-44C2-9B9C-1F5E7A8397F5Q39033266-E26362B4-FD08-43E7-92DF-13B4681C8E75Q39146304-6C03305B-DA19-4EA8-B4C9-F75E353E4530Q39420068-42941445-6330-4A1B-BFC8-F46ECF3180E2Q40475342-96DDA980-2E13-4A88-B8E1-F715369A3735Q41043827-5F394438-8522-4FFA-BF8F-9672BB7368FFQ44446237-4D44AFA9-A455-410B-B76F-696B2AFAB112Q46104348-388A347B-FD63-4945-B5F4-324A00AED7A7Q46201527-412C5E38-A142-49DE-8D62-36DE41870C53Q46490615-6462D3DB-7BF2-4798-8544-AD78B4B50D64Q46829238-7C8E1E23-4CAF-4E7B-AA58-E38B50276149Q47819008-29582561-2E6E-407D-BFD8-3A7C3BE29B17Q48157920-956EF1A7-92F0-4375-BB3B-61F6C06F5ADBQ48245298-49FAC37C-B49C-475C-93C7-F6A9461D288AQ48351852-4696BD62-44DB-4FB4-A93C-86DA7614E90BQ48564102-2B5E5279-7CE3-41F7-AF53-6837AD5ABFB4Q48687987-626A5B68-C0A7-48BE-99F7-A2A37471BAF7Q48832361-CED855B0-00FE-45D6-A6F8-C46B4CDFB911Q48957322-CC48535F-FFA1-47B9-AD2B-6FCEB95B69D2Q50315378-0371729e-4eca-28ba-ca2d-5503eeb55e28Q50491726-6CA4D3DE-6054-487D-BE16-77A6695BE672Q50537912-7F5C592C-AB5B-40A2-8481-5BC8E51D794CQ50962818-A04850BC-B495-4CC8-A693-2F76D905ED4CQ51175504-543BF0E8-3284-44CC-BD93-6E517BAECB43
P50
description
Chemiker und Hochschullehrer
@de
researcher (HZDR)
@en
wetenschapper
@nl
name
Jörg Steinbach
@ast
Jörg Steinbach
@de
Jörg Steinbach
@en
Jörg Steinbach
@es
Jörg Steinbach
@nl
Jörg Steinbach
@sl
type
label
Jörg Steinbach
@ast
Jörg Steinbach
@de
Jörg Steinbach
@en
Jörg Steinbach
@es
Jörg Steinbach
@nl
Jörg Steinbach
@sl
prefLabel
Jörg Steinbach
@ast
Jörg Steinbach
@de
Jörg Steinbach
@en
Jörg Steinbach
@es
Jörg Steinbach
@nl
Jörg Steinbach
@sl
P1053
B-5940-2015
P106
P21
P31
P3829
P496
0000-0002-1708-6440
P569
2000-01-01T00:00:00Z